REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $21,000 | +250.0% | 40,400 | 0.0% | 0.00% | – |
Q4 2016 | $6,000 | -33.3% | 40,400 | 0.0% | 0.00% | – |
Q3 2016 | $9,000 | -10.0% | 40,400 | 0.0% | 0.00% | – |
Q2 2016 | $10,000 | -28.6% | 40,400 | 0.0% | 0.00% | – |
Q1 2016 | $14,000 | -6.7% | 40,400 | 0.0% | 0.00% | – |
Q4 2015 | $15,000 | -28.6% | 40,400 | 0.0% | 0.00% | – |
Q3 2015 | $21,000 | -12.5% | 40,400 | 0.0% | 0.00% | – |
Q2 2015 | $24,000 | -20.0% | 40,400 | 0.0% | 0.00% | – |
Q1 2015 | $30,000 | +30.4% | 40,400 | +25.5% | 0.00% | – |
Q4 2014 | $23,000 | -20.7% | 32,200 | -10.6% | 0.00% | – |
Q3 2014 | $29,000 | -9.4% | 36,000 | 0.0% | 0.00% | – |
Q2 2014 | $32,000 | -17.9% | 36,000 | 0.0% | 0.00% | – |
Q1 2014 | $39,000 | +34.5% | 36,000 | -50.0% | 0.00% | – |
Q4 2013 | $29,000 | +81.2% | 72,000 | +100.0% | 0.00% | – |
Q3 2013 | $16,000 | 0.0% | 36,000 | 0.0% | 0.00% | – |
Q2 2013 | $16,000 | – | 36,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|